These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2877531)

  • 21. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
    Pecknold JC
    J Psychiatry Neurosci; 1993 Mar; 18(2):82-4. PubMed ID: 8096393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines.
    Menza MA; Murray GB; Holmes VF; Rafuls WA
    Heart Lung; 1988 May; 17(3):238-41. PubMed ID: 2896642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
    Lovett WC; Stokes DK; Taylor LB; Young ML; Free SM; Phelan DG
    J Clin Psychiatry; 1987 Jun; 48(6):234-6. PubMed ID: 3294815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of neuroleptics on behavioral symptoms in disturbed elderly patients.
    Ciccone PE
    J Clin Psychiatry; 1987 Dec; 48(12):497-8. PubMed ID: 3693339
    [No Abstract]   [Full Text] [Related]  

  • 27. A small double-blind comparison of ketazolam and diazepam in the treatment of anxiety by general practitioners in Great Britain.
    Davies JG; Rose AJ
    Br J Clin Pract; 1983 Apr; 37(4):136-9. PubMed ID: 6136293
    [No Abstract]   [Full Text] [Related]  

  • 28. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
    Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M
    Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of neuroleptic therapy on the structure of an episode in acute alcoholic psychoses].
    Kolotilin GF; Mostovoĭ SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(6):894-7. PubMed ID: 2888249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seizures associated with clozapine treatment in a state hospital.
    Wilson WH; Claussen AM
    J Clin Psychiatry; 1994 May; 55(5):184-8. PubMed ID: 8071267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depersonalisation--symptoms, meaning, therapy.
    Nuller YL
    Acta Psychiatr Scand; 1982 Dec; 66(6):451-8. PubMed ID: 6129777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sidnocarb correction of the adverse effects of benzodiazepine tranquilizers].
    Valueva LN; Tozhanova NM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(8):92-7. PubMed ID: 6127851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
    Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
    Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical activities of a new bezodiazepine: cloxazolam].
    Singer L; Krieger-Finance F; Danion JM
    Ann Med Psychol (Paris); 1980 Jan; 138(1):95-103. PubMed ID: 6104462
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of Leponex treatment of schizophrenia].
    Wojdyslawska I; Siuchnińska H; Góraj A
    Psychiatr Pol; 1975; 9(1):45-50. PubMed ID: 235143
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of anxious-depressive syndromes with tofizopam].
    Novotný V; Molcan J; Sipkovská E; Knoíková M
    Act Nerv Super (Praha); 1979 Oct; 21(3):152-3. PubMed ID: 42263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.